{
    "eid": "2-s2.0-84920592036",
    "title": "Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms",
    "cover-date": "2014-08-14",
    "subject-areas": [
        {
            "$": "Gastroenterology",
            "@code": "2715"
        }
    ],
    "keywords": [
        "Early viral kinetics",
        "Genotype 6",
        "Hepatitis C virus",
        "Interleukin-28B",
        "Rs12979860"
    ],
    "authors": [
        "Srunthron Akkarathamrongsin"
    ],
    "citedby-count": 4,
    "ref-count": 24,
    "ref-list": [
        "The global burden of hepatitis C",
        "HCV genetic variability: From quasispecies evolution to genotype classification",
        "Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource",
        "Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand",
        "Systematic review: Asian patients with chronic hepatitis C infection",
        "Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-\u03b1 therapy",
        "Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase",
        "Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon",
        "Hepatitis c virus genotypes 1 and 2 respond to interferon-a with different",
        "Hepatitis C treatment response kinetics and impact of baseline predictors",
        "IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C",
        "Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin",
        "IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1",
        "HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism",
        "Response-guided therapy for patients with hepatitis C virus genotype 6 infection: A pilot study",
        "Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1",
        "High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients",
        "Genetic variation in IL28B and spontaneous clearance of hepatitis C virus",
        "Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus",
        "Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus",
        "Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Na\u00efve Patients With Chronic Hepatitis C",
        "'Favourable' IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype 3a infection and do not predict a sustained virological response after 24 weeks of therapy",
        "Test of IL28B Polymorphisms in Chronic Hepatitis C Patients Treated with PegIFN and Ribavirin Depends on HCV Genotypes: Results from a Meta-Analysis",
        "Current and future therapies for hepatitis C virus infection"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}